Literature DB >> 30157420

Muscarinic Acetylcholine Receptors Chrm1 and Chrm3 Are Essential for REM Sleep.

Yasutaka Niwa1, Genki N Kanda2, Rikuhiro G Yamada3, Shoi Shi4, Genshiro A Sunagawa5, Maki Ukai-Tadenuma6, Hiroshi Fujishima3, Naomi Matsumoto7, Koh-Hei Masumoto8, Mamoru Nagano9, Takeya Kasukawa10, James Galloway11, Dimitri Perrin12, Yasufumi Shigeyoshi9, Hideki Ukai6, Hiroshi Kiyonari13, Kenta Sumiyama7, Hiroki R Ueda14.   

Abstract

Sleep regulation involves interdependent signaling among specialized neurons in distributed brain regions. Although acetylcholine promotes wakefulness and rapid eye movement (REM) sleep, it is unclear whether the cholinergic pathway is essential (i.e., absolutely required) for REM sleep because of redundancy from neural circuits to molecules. First, we demonstrate that synaptic inhibition of TrkA+ cholinergic neurons causes a severe short-sleep phenotype and that sleep reduction is mostly attributable to a shortened sleep duration in the dark phase. Subsequent comprehensive knockout of acetylcholine receptor genes by the triple-target CRISPR method reveals that a similar short-sleep phenotype appears in the knockout of two Gq-type acetylcholine receptors Chrm1 and Chrm3. Strikingly, Chrm1 and Chrm3 double knockout chronically diminishes REM sleep to an almost undetectable level. These results suggest that muscarinic acetylcholine receptors, Chrm1 and Chrm3, are essential for REM sleep.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chrm1; Chrm3; REM sleep; Tet system; TrkA; acetylcholine; sleep; tTR; triple-target CRISPR

Mesh:

Substances:

Year:  2018        PMID: 30157420     DOI: 10.1016/j.celrep.2018.07.082

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  26 in total

Review 1.  In vivo cell type-specific CRISPR gene editing for sleep research.

Authors:  Hiroshi Yamaguchi; Luis de Lecea
Journal:  J Neurosci Methods       Date:  2018-11-12       Impact factor: 2.390

2.  Reduced thermal tolerance in a coral carrying CRISPR-induced mutations in the gene for a heat-shock transcription factor.

Authors:  Phillip A Cleves; Amanda I Tinoco; Jacob Bradford; Dimitri Perrin; Line K Bay; John R Pringle
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-09       Impact factor: 11.205

3.  A Rare Mutation of β1-Adrenergic Receptor Affects Sleep/Wake Behaviors.

Authors:  Guangsen Shi; Lijuan Xing; David Wu; Bula J Bhattacharyya; Christopher R Jones; Thomas McMahon; S Y Christin Chong; Jason A Chen; Giovanni Coppola; Daniel Geschwind; Andrew Krystal; Louis J Ptáček; Ying-Hui Fu
Journal:  Neuron       Date:  2019-08-28       Impact factor: 17.173

4.  Sleep and Late-Onset Alzheimer's Disease: Shared Genetic Risk Factors, Drug Targets, Molecular Mechanisms, and Causal Effects.

Authors:  Dongze Chen; Xinpei Wang; Tao Huang; Jinzhu Jia
Journal:  Front Genet       Date:  2022-05-17       Impact factor: 4.772

5.  Successful treatment of drug-resistant cataplexy with the anticholinergic drug tropatepine.

Authors:  Milan Nigam; Smaranda Leu-Semenescu; Isabelle Arnulf
Journal:  J Clin Sleep Med       Date:  2021-04-01       Impact factor: 4.062

6.  Hypermethylation of PI3K-AKT signalling pathway genes is associated with human neural tube defects.

Authors:  Tian Tian; Xinyuan Lai; Kuanhui Xiang; Xiao Han; Shengju Yin; Robert M Cabrera; John W Steele; Yunping Lei; Xuanye Cao; Richard H Finnell; Linlin Wang; Aiguo Ren
Journal:  Epigenetics       Date:  2021-02-17       Impact factor: 4.528

7.  Progress of genome editing technology and developmental biology useful for radiation research.

Authors:  Kento Miura; Atsuo Ogura; Kohei Kobatake; Hiroaki Honda; Osamu Kaminuma
Journal:  J Radiat Res       Date:  2021-05-05       Impact factor: 2.724

Review 8.  Towards organism-level systems biology by next-generation genetics and whole-organ cell profiling.

Authors:  Yoichi Minami; Yufei Yuan; Hiroki R Ueda
Journal:  Biophys Rev       Date:  2021-11-18

9.  Molecular Regulation of Betulinic Acid on α3β4 Nicotinic Acetylcholine Receptors.

Authors:  Shinhui Lee; Woog Jung; Sanung Eom; Hye Duck Yeom; Heui-Dong Park; Junho H Lee
Journal:  Molecules       Date:  2021-05-01       Impact factor: 4.411

10.  Safety and Pharmacokinetics of HTL0018318, a Novel M1 Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly Subjects.

Authors:  Charlotte Bakker; Jasper van der Aart; Geert Labots; Jan Liptrot; David M Cross; Erica S Klaassen; Steve Dickinson; Tim Tasker; Geert Jan Groeneveld
Journal:  Drugs R D       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.